1、S-1/A 1 ea0215597-01.htm REGISTRATION STATEMENTAs filed with the Securities and Exchange Commission on September 27,2024.Registration No.333-272501UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,DC 20549Amendment No.2 toFORM S-1REGISTRATION STATEMENTUnderTHE SECURITIES ACT OF 1933Heart Tes
2、t Laboratories,Inc.(Exact name of registrant as specified in its charter)_Texas33451026-1344466(State or otherjurisdiction ofincorporation ororganization)(Primary StandardIndustrialClassification CodeNumber)(I.R.S.EmployerIdentification Number)550 Reserve St,Suite 360Southlake,Texas 76092682-237-778
3、1(Address,includingzipcode,andtelephonenumber,includingareacode,ofregistrantsprinciDanielle Watson550 Reserve St,Suite 360Southlake,Texas 76092682-237-7781(Name,address,including zip code,and telephone number,including areacode,of agent for service)_Copies to:Sasha AblovatskiyJonathan ShechterFoley
4、Shechter Ablovatskiy LLP641 Lexington Avenue,14th FloorNewYork,NewYork 10022Tel:(212)335-0466David E.DanovitchAngela GomesSullivan&Worcester LLP1251 Avenue of the AmericasNewYork,NewYork 10020(212)660-3000_Approximate date of commencement of proposed sale to the public:As soon as practicable after t
5、heeffective date of this Registration Statement.If any of the securities being registered on this Form are to be offered on a delayed or continuous basispursuant to Rule415 under the Securities Actof1933,check the following box:If this Form is filed to register additional securities for an offering
6、pursuant to Rule462(b)underthe Securities Act,please check the following box and list the Securities Act registration statement number ofthe earlier effective registration statement for the same offering.If this Form is a post-effective amendment filed pursuant to Rule462(c)under the Securities Act,